CytoSorbents Corporation (CTSO)

[orangecat]

How long should it take for a tiny R&D biotech to build its own sales force and secure marketing partners to transition into a commercial medical device company?

In order to derisk cytosorb they took a path fiscally responsible for us shareholders. They did not launch a massive pivotal do or die US study, but instead chose the route of testing the waters with early adopters in Germany and a few other select countries to prove there is a market for the product. The investigators initiated studies and Cytosorb registry are the spark that should get sales burning. The company has said a few times recently that they consider the product derisked. That tells me that they are seeing, from the increasing sales to existing customers, that there is indeed and need and demand for the product.

BTW. CE mark happened in 2012, not in 2008 as your 9 year comment light suggest.